ClinicalTrials.gg
RecruitingNCT06579443RIDDLEUpdated Oct 27, 2026

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

An observational study in Inflammatory Bowel Diseases, Crohn Disease and Ulcerative Colitis, sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Recruiting at 6 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by University Hospitals Coventry and Warwickshire NHS Trust · Observational

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 3 months later.
Updated Oct 27, 2026Primary completion movedStudy completion movedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

To determine if robotic surgery can be performed for inflammatory bowel disease (IBD) patients, to ascertain the optimal robotic set up for multi-quadrant IBD operations and evaluate clinical outcomes in robotic compared to laparoscopic surgery.

02

Conditions studied

  • Inflammatory Bowel Diseases
  • Crohn Disease
  • Ulcerative Colitis

Keywords

  • Robotic IBD surgery
  • Laparoscopic IBD surgery
03

In context

Inflammatory Bowel Diseases

1,550 studies on the registry are indexed under Inflammatory Bowel Diseases; 426 are open to participants now.

This study's planned enrollment of 100 is below the median of 140 across 626 observational studies indexed under Inflammatory Bowel Diseases.

Browse Inflammatory Bowel Diseases studies →

Lead sponsor

University Hospitals Coventry and Warwickshire NHS Trust is the lead sponsor of 57 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing surgery for inflammatory bowel disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or over
  • Undergoing IBD surgery using MIS (minimally invasive surgery) techniques
  • Histological/radiological evidence of inflammatory bowel disease

Exclusion criteria

Exclusion Criteria:

  • Planned open surgical approach
  • Lacks capacity to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. To see if robotic surgery is technically feasible for patients with inflammatory bowel disease measured during intra-operative procedure that includes: estimated blood loss in mL.

    Time frame: 12 months

  2. Port placement using position of ports on the abdomen marked in a diagram during surgical procedure.

    Time frame: 12 months

  3. Docking of robotic arm in robotic surgery using number of times the docking was done with start and end docking time in HH:MM.

    Time frame: 12 months

  4. Operative time using time of surgery performed in HH:MM.

    Time frame: 12 months

07

Study locations

6 of 6 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Nov 2027, 40 months after the start.

Of 243 non-industry observational studies under Inflammatory Bowel Diseases, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 132. This study's planned 40 months is close to that.

Counting every sponsor, half of 280 studies reached it within 36 months; a quarter within 20 and three quarters within 122.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: primary completion May 2026 → Nov 2027 and completion Jun 2026 → Jun 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2024
First posted
Aug 30, 2024
StartActual
Jul 12, 2024
Primary completionEst.
Nov 2027was May 2026
CompletionEst.
Jun 2028was Jun 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
May 2026→Nov 2027
Oct 27, 2026
Study completion
Jun 2026→Jun 2028
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Primary completion May 2026→Nov 2027
    Study completion Jun 2026→Jun 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06579443
Lead sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Responsible party
Sponsor
First posted
Aug 30, 2024
Start date
Jul 12, 2024
Primary completion
Nov 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Oct 27, 2026

Study contacts

Manreet Thind
Contact
Riddlestudyoffice@uchw.nhs.uk
02476966581

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion